Fernwood Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.45M Sell
88,200
-1,300
-1% -$20.2K 0.51% 50
2024
Q3
$1.32M Buy
89,500
+900
+1% +$14.1K 0.43% 60
2024
Q2
$1.23M Buy
88,600
+3,500
+4% +$49.6K 0.38% 65
2024
Q1
$1.34M Buy
85,100
+8,600
+11% +$133K 0.39% 65
2023
Q4
$1.24M Sell
76,500
-1,800
-2% -$29.5K 0.41% 68
2023
Q3
$963K Sell
78,300
-800
-1% -$11.9K 0.35% 78
2023
Q2
$1.27M Buy
79,100
+2,600
+3% +$42.8K 0.45% 61
2023
Q1
$1.33M Buy
76,500
+300
+0.4% +$4.27K 0.51% 59
2022
Q4
$704K Buy
76,200
+6,300
+9% +$58.7K 0.29% 92
2022
Q3
$602K Sell
69,900
-385
-0.5% -$3.82K 0.25% 101
2022
Q2
$573K Buy
70,285
+4,840
+7% +$46.2K 0.25% 106
2022
Q1
$795K Buy
65,445
+8,500
+15% +$179K 0.28% 94
2021
Q4
$1.94M Buy
56,945
+26,615
+88% +$1.04M 0.64% 46
2021
Q3
$1.46M Buy
30,330
+4,000
+15% +$185K 0.5% 58
2021
Q2
$1.19M Buy
26,330
+3,000
+13% +$133K 0.39% 76
2021
Q1
$1.13M Buy
23,330
+1,050
+5% +$54.7K 0.41% 76
2020
Q4
$1.2M Buy
22,280
+9,680
+77% +$437K 0.47% 61
2020
Q3
$465K Buy
12,600
+5,600
+80% +$208K 0.22% 112
2020
Q2
$217K Buy
+7,000
New +$194K 0.11% 154

Other funds holding NEO

Fernwood Investment Management's NEO Position: Q4 2024 in Review

Fernwood Investment Management reduced its NeoGenomics (NEO) stake by 1.5% in Q4 2024, selling an estimated $20.2K and leaving 88,200 shares worth $1.45M. The position accounts for 0.51% of the portfolio, ranked #50.

Fernwood Investment Management first reported a position in NEO in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.94M in Q4 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Fernwood Investment Management held 88,200 shares of NeoGenomics worth $1.45M as of Q4 2024.
  • Fernwood Investment Management sold 1,300 NeoGenomics shares in Q4 2024, an estimated $20.2K.
  • NeoGenomics made up 0.51% of Fernwood Investment Management's portfolio in Q4 2024, its #50 holding.
  • Fernwood Investment Management first reported a position in NeoGenomics in Q2 2020 and has held it in 19 quarters since.
  • Fernwood Investment Management's NeoGenomics position peaked at $1.94M in Q4 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.